Literature DB >> 30916811

STAT3 signalling pathway is implicated in keloid pathogenesis by preliminary transcriptome and open chromatin analyses.

Yun-Shain Lee1,2, Ya-Chen Liang2,3, Ping Wu3, David A Kulber4,5,6, Kylie Tanabe6, Cheng-Ming Chuong2,3,7, Randall Widelitz3, Tai-Lan Tuan1,8.   

Abstract

Keloids are wounding-induced fibroproliferative human tumor-like skin scars of complex genetic makeup and poorly defined pathogenesis. To reveal dynamic epigenetic and transcriptome changes of keloid fibroblasts, we performed RNA-seq and ATAC-seq analysis on an early passage keloid fibroblast cell strain and its paired normal control fibroblasts. This keloid strain produced keloid-like scars in a plasma clot-based skin equivalent humanized keloid animal model. RNA-seq analysis reveals gene ontology terms including hepatic fibrosis, Wnt-β-catenin, TGF-β, regulation of epithelial-mesenchymal transition (EMT), STAT3 and adherens junction. ATAC-seq analysis suggests STAT3 signalling is the most significantly enriched gene ontology term in keloid fibroblasts, followed by Wnt signalling (Wnt5) and regulation of the EMT pathway. Immunohistochemistry confirms that STAT3 (Tyr705 phospho-STAT3) is activated and β-catenin is up-regulated in the dermis of keloid clinical specimens and keloid skin equivalent implants from the humanized mouse model. A non-linear dose-response of cucurbitacin I, a selective JAK2/STAT3 inhibitor, in collagen type I expression of keloid-derived plasma clot-based skin equivalents implicates a likely role of STAT3 signalling in keloid pathogenesis. This work also demonstrates the utility of the recently established humanized keloid mouse model in exploring the mechanism of keloid formation.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  animal model; artificial skin; fibroblasts

Year:  2019        PMID: 30916811      PMCID: PMC6488383          DOI: 10.1111/exd.13923

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  27 in total

Review 1.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

2.  Functional implications of the IL-6 signaling pathway in keloid pathogenesis.

Authors:  Mohammad Ghazizadeh; Mamiko Tosa; Hajime Shimizu; Hiko Hyakusoku; Oichi Kawanami
Journal:  J Invest Dermatol       Date:  2006-10-05       Impact factor: 8.551

Review 3.  Molecular dissection of abnormal wound healing processes resulting in keloid disease.

Authors:  Barbara Shih; Elloise Garside; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Wound Repair Regen       Date:  2009-12-11       Impact factor: 3.617

4.  Keloids show regional distribution of proliferative and degenerate connective tissue elements.

Authors:  Shamin Bux; Anil Madaree
Journal:  Cells Tissues Organs       Date:  2009-07-29       Impact factor: 2.481

5.  Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration.

Authors:  C P Lim; T-T Phan; I J Lim; X Cao
Journal:  Oncogene       Date:  2006-04-17       Impact factor: 9.867

6.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Authors:  Michelle A Blaskovich; Jiazhi Sun; Alan Cantor; James Turkson; Richard Jove; Saïd M Sebti
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

7.  Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis.

Authors:  Johanna Canady; Stephanie Arndt; Sigrid Karrer; Anja K Bosserhoff
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

Review 8.  Wound healing in development.

Authors:  Yun-Shain Lee; Annette Wysocki; David Warburton; Tai-Lan Tuan
Journal:  Birth Defects Res C Embryo Today       Date:  2012-09

9.  Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates.

Authors:  R Bagabir; R J Byers; I H Chaudhry; W Müller; R Paus; A Bayat
Journal:  Br J Dermatol       Date:  2012-11       Impact factor: 9.302

10.  Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.

Authors:  Gyuman Park; Byung Sun Yoon; Jai-Hee Moon; Bona Kim; Eun Kyoung Jun; Sejong Oh; Hyunggee Kim; Hea Joon Song; Joo Young Noh; Chilhwan Oh; Seungkwon You
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

View more
  12 in total

1.  Skin epigenetics.

Authors:  Bogi Andersen; Sarah Millar
Journal:  Exp Dermatol       Date:  2021-07-05       Impact factor: 4.511

Review 2.  Primary Ciliary Signaling in the Skin-Contribution to Wound Healing and Scarring.

Authors:  Mayu Hosio; Viljar Jaks; Heli Lagus; Jyrki Vuola; Rei Ogawa; Esko Kankuri
Journal:  Front Cell Dev Biol       Date:  2020-11-13

Review 3.  Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Exp Dermatol       Date:  2020-07-06       Impact factor: 3.960

4.  Inference and analysis of cell-cell communication using CellChat.

Authors:  Suoqin Jin; Christian F Guerrero-Juarez; Lihua Zhang; Ivan Chang; Raul Ramos; Chen-Hsiang Kuan; Peggy Myung; Maksim V Plikus; Qing Nie
Journal:  Nat Commun       Date:  2021-02-17       Impact factor: 17.694

5.  Differential responses to folic acid in an established keloid fibroblast cell line are mediated by JAK1/2 and STAT3.

Authors:  Katelyn J McCann; Manoj Yadav; Mohammadali E Alishahedani; Alexandra F Freeman; Ian A Myles
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

6.  RNA Sequencing Keloid Transcriptome Associates Keloids With Th2, Th1, Th17/Th22, and JAK3-Skewing.

Authors:  Jianni Wu; Ester Del Duca; Michael Espino; Alyssa Gontzes; Inna Cueto; Ning Zhang; Yeriel D Estrada; Ana B Pavel; James G Krueger; Emma Guttman-Yassky
Journal:  Front Immunol       Date:  2020-11-23       Impact factor: 7.561

7.  Fostering a healthy culture: Biological relevance of in vitro and ex vivo skin models.

Authors:  Scott X Atwood; Maksim V Plikus
Journal:  Exp Dermatol       Date:  2021-02-10       Impact factor: 3.960

8.  Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a.

Authors:  Chuan-Jue Cui; Jing-Lu Jin; Lin-Na Guo; Jing Sun; Na-Qiong Wu; Yuan-Lin Guo; Geng Liu; Qian Dong; Jian-Jun Li
Journal:  J Transl Med       Date:  2020-05-12       Impact factor: 5.531

Review 9.  Scars or Regeneration?-Dermal Fibroblasts as Drivers of Diverse Skin Wound Responses.

Authors:  Dongsheng Jiang; Yuval Rinkevich
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

10.  Treatment of keloids through Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway.

Authors:  Wenchang Lv; Min Wu; Yuping Ren; Xiao Luo; Weijie Hu; Qi Zhang; Yiping Wu
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.